For miRNA transcriptome analysis, two primary ovarian cell clones with CD24-low (CD14.2) and CD24-high (C4) expression were obtained from an ovarian cancer patient (Fig. 1A). This evidence concerns the gene CD14 and ovarian carcinoma.